Core Laboratories Inc.
CLB
$12.62
$0.302.44%
NYSE
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -3.84% | 2.93% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -3.84% | 2.93% | |||
| Cost of Revenue | -0.57% | 3.76% | |||
| Gross Profit | -16.50% | -0.20% | |||
| SG&A Expenses | 5.58% | -16.49% | |||
| Depreciation & Amortization | -0.33% | -2.49% | |||
| Other Operating Expenses | 78.05% | -13.53% | |||
| Total Operating Expenses | 0.54% | 1.74% | |||
| Operating Income | -34.91% | 12.19% | |||
| Income Before Tax | -30.85% | 30.44% | |||
| Income Tax Expenses | -13.11% | 29.98% | |||
| Earnings from Continuing Operations | -37.78% | 30.62% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 74.52% | -63.92% | |||
| Net Income | -36.97% | 30.04% | |||
| EBIT | -34.91% | 12.19% | |||
| EBITDA | -28.64% | 9.21% | |||
| EPS Basic | -38.07% | 30.03% | |||
| Normalized Basic EPS | -46.28% | 21.81% | |||
| EPS Diluted | -38.00% | 31.58% | |||
| Normalized Diluted EPS | -45.27% | 21.72% | |||
| Average Basic Shares Outstanding | 1.81% | 0.03% | |||
| Average Diluted Shares Outstanding | -0.10% | 0.16% | |||
| Dividend Per Share | 0.00% | 0.00% | |||
| Payout Ratio | 0.59% | -0.23% | |||